FDA's confusing warning letters BPC 157: Miracle Healing Peptide or Hidden Danger? Compounded "semaglutide" is not FDA approved semaglutide.com The FDA has sent 30 warning letters to telehealth companies for falsely marketing compounded GLP 1s, which are not FDA approved and can pose risks to patients. FULL STORY:https: tinyurl.com 3ztf9uj2 FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and